Merrimack Pharmaceuticals raises $60 million
June 11, 2008 03:15 PM
E-mail|
|Comments
()|
Text size
–
+
Merrimack Pharmaceuticals Inc. a Cambridge biotechnology company, said it raised $60 million in its sixth round of private financing.
Since its founding in 1993, the company has raised more than $200 million.
The company is developing treatments for cancer and autoimmune diseases. Merrimack's lead experimental drug, a treatment for rheumatoid arthritis, is in mid-stage clinical trials.
(By Todd Wallack, Globe staff)
Comment
Permalink
E-mail
